VERU logo
VERU NASDAQ US

Veru Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jul 1990
$2.29
▲ +$0.02 (+0.88%)
Vol 32K
3
Quality Score
fail
Mkt Cap
$34.3M
ROE
-111.7%
Margin
-223.9%
D/E
0.00
Beta
-1.39
52W
$2–$14

Wall Street Consensus

8 analysts · Apr 2026
3
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Similar Stocks

MIRA
MIRA Pharmaceuticals Inc
$63.2M
NTRB
Nutriband Inc
$55.3M
TELO
Telomir Pharmaceuticals Inc
$45.7M
SCYX
SCYNEXIS Inc
$26.5M
GRCE
Grace Therapeutics, Inc
$53.5M
TLPH
Talphera Inc
$53.1M
ANEB
Anebulo Pharmaceuticals Inc
$41.5M
AYTU
Aytu Biopharma Inc
$26.5M
TVRD
Tvardi Therapeutics Inc
$40.3M

Earnings

Beat rate: 100.0%
Next Report May 06, 2026
EPS Estimate: $-0.29
Quarter EPS Est EPS Act Surprise
Jun 2026 $-0.29 — —
Dec 2025 $-0.48 $-0.26 +$0.22
Sep 2025 $-0.43 $0.10 +$0.53
Jun 2025 $-0.54 $-0.50 +$0.04

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -137.2% -108.5% -108.5% -108.5% -108.5% -111.7%
P/E (TTM) — — — — — —
Net Margin — -223.9% -223.9% -223.9% -223.9% -223.9%
Gross Margin — 34.7% 34.7% 34.7% 34.7% 34.7%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.42 2.42 2.42 2.42 2.42 2.43

Key Ratios

ROA (TTM)
-70.1%
P/S (TTM)
2.03
P/B
3.0
EPS (TTM)
$-1.55
CF/Share
$-1.49
Rev Growth 3Y
-34.9%
52W High
$14.20
52W Low
$2.11
$2.11 52-Week Range $14.20

How does VERU compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

VERU AARD ACB ACRS ADIL

VERU valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
2.0
▼ 59% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
3.0
▲ 43% above peers (2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

VERU profitability vs Pharmaceuticals peers

ROE
-111.7%
▼ 106% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-223.9%
▼ 373% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
34.7%
▼ 49% below peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-70.1%
▼ 87% below peers (-37.4%)
vs Peers
vs Industry
Weak

VERU financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
2.4
▼ 28% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
-1.4
▼ 248% below peers (0.9)
vs Peers
vs Industry
More volatile

VERU fundamentals radar

VERU Peer median Industry

VERU profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VERU vs peers: key metrics

Latest News

No related news yet